Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 5:01 AM
Ignite Modification Date:
2025-12-25 @ 5:01 AM
NCT ID:
NCT03699618
Eligibility Criteria:
Inclusion Criteria:
* Signed informed consent and authorization of use and disclosure of protected health information
* Age 50 years or older
* Presence of subretinal hemorrhage (SRH) involving the fovea in patients with NVAMD including polypoidal choroidal vasculopathy (PCV)
Exclusion Criteria:
* SFH in the study eye due to causes other than NVAMD
* Media opacity due to concurrent vitreous hemorrhage or cataracts that preclude adequate imaging
* Substantial loss of VA due to condition other than AMD
* Limited visual potential from substantial atrophy or fibrosis in fovea
* Poor visual potential with known permanent reduction in visual acuity prior to SFH
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
50 Years
Study:
NCT03699618
Study Brief:
Protocol Section:
NCT03699618